Διοίκηση
Η διοίκηση της LEO Pharma Α/S έχει μια δομή δύο επιπέδων που αποτελείται από την Ηγετική Ομάδα και το Διοικητικό Συμβούλιο. Τα δύο σώματα είναι ανεξάρτητα.
Ηγετική Ομάδα της LEO Pharma Α/S
-
Christophe Bourdon, CEO LEO Pharma
-
Anders Kronborg, Chief Financial Officer, Global Finance and Business Services
-
Guillaume Clément, Executive Vice President, Thrombosis & Special Projects
-
Brian Hilberdink, Executive Vice President, Region North America
-
Becki Morison, Executive Vice President, Global Product Strategy & International Operations
-
Sven Hauptmann, Executive Vice President, Global Product Supply
-
Jörg Möller, Executive Vice President, Global Research & Development
-
Dennis Schmidt Pedersen, Executive Vice President, Global People
Διοικητικό Συμβούλιο
Το Διοικητικό Συμβούλιο έχει εποπτικό ρόλο με άμεση μεσολάβηση σε βασικές αποφάσεις για το μέλλον της LEO Pharma.
-
Jesper Brandgaard, Chair, Board Member since 2021
-
Peter Haahr, Board Member since 2021
-
Franck Maréno, Employee elected, Board Member since 2018
-
Jannie Kogsbøll, Employee elected, Board Member since 1998
-
Jan van de Winkel, Board Member since 2017
-
Jesper Mailind, Vice-chair, Board Member since 2018
-
Karin Attermann, Employee elected, Board Member since 2008
-
Signe Maria Christensen, Employee elected, Board Member since 2018
-
Elisabeth Svanberg, Board Member since 2022
-
Lotte Hjortshøj Larsen, Employee elected Board member, Diploma Graduate
-
Lars Green, Board member since 2021